The neurobiology of eating disorders [EDs; anorexia nervosa (AN), bulimia nervosa (BN), and binge eating disorder (BED)] remains poorly understood. Here, I describe how neuroimaging, accompanied by peripheral endocrine measures, can provide insights into the neurobiological drivers of eating disorders. Orexins/hypocretins, glucagon-like peptide-1 receptor (GLP1R) agonists, and psilocybin are highlighted as avenues for investigation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.molmed.2023.12.001 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!